期刊文献+

Prophylaxis of tumor through oral administration of IL-12 GM-CSF gene carried by live attenuated salmonella 被引量:1

Prophylaxis of tumor through oral administration of IL-12 GM-CSF gene carried by live attenuated salmonella
原文传递
导出
摘要 A live attenuated AraA autotrophic mutant of Salmonella typhimurium (SL3261) was used as carrier for eukaryotic expression vectors EGFPN1, pCMVmIL-12, pCMVWL-12, pCMVmGM-CSF and PCMVhGM-CSF and was administered orally to BALB/c and C57BL/6 mice. After 6 weeks, these mice were challenged with 4T1 and Lewis tumor cells respectively. GFP expression and gene integration could be detected in mice’s livers, spleens, intestines, kidneys and tumors. The serum level of cytokines increasedsignificantly in treated mice, so did the ratio of CD8+/CD4+,which resulted in the tumor regression and prolongation of the survival time of those mice. These researches laid an experimental foundation for the tumor gene therapy using live attenuated salmonella. A live attenuated AraA- autotrophic mutant ofSalmonella typhimurium (SL3261) was used as carrier for eukaryotic expression vectors EGFPN1, pCMVmIL-12, pCMVhIL-12, pCMVmGM-CSF and pCMVhGM-CSF and was administered orally to BALB/c and C57BL/6 mice. After 6 weeks, these mice were challenged with 4T1 and Lewis tumor cells respectively. GFP expression and gene integration could be detected in mice’s livers, spleens, intestines, kidneys and tumors. The serum level of cytokines increased significantly in treated mice, so did the ratio of CD 8 + /CD 4 + , which resulted in the tumor regression and prolongation of the survival time of those mice. These researches laid an experimental foundation for the tumor gene therapy using live attenuated salmonella.
出处 《Chinese Science Bulletin》 SCIE EI CAS 2001年第13期1107-1112,共6页
关键词 ORAL ADMINISTRATION gene therapy ATTENUATED salmonella. oral administration gene therapy attenuated salmonella
  • 相关文献

参考文献11

  • 1Aruga A,Tanigawak K,Aruga E,et al.Enhanced adjuvant effect of granulocyte-macrophage colony-stimulating factor plus interleukin-12 compared with either alone in vaccine-induced tumor immunity. Cancer Gene Therapy . 1999
  • 2Medina E,Paglia P,Nikolaus T,et al.Pathogenicity island 2 mutants of Salmonella typhimurium are efficient carriers for heterologous antigens and enable modulation of immune responses. Infection and Immunity . 1999
  • 3Urashima M,Suzuki H,Yuza Y,et al.An oral CD40 ligand gene therapy against lymphoma using attenuated Salmonella typhimurium. Blood . 2000
  • 4Darji A,Guzman CA,Gerstel B,et al.Oral somatic transgene vaccination using attenuated Salmonella typhimurium. Cell . 1997
  • 5Sambrook J,Fritsch EF,Maniatis T.Molecular Cloning:A Laboratory Manual. . 1989
  • 6During MJ,Symes CW,Lawlor PA,et al.An oral vaccine against NMDAR1 with efficacy in experimenral stroke and epilepsy. Science . 2000
  • 7Low K B,Ittensohn M,Trung L,et al.Lipid a mutant Salmonella with suppressed virulence and TNFαinduction retain tumor-targeting in vivo. Nature Biotechnology . 1999
  • 8Paglia P,Medina E,Arioli I,et al.Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a marine fibrosarcoma. Blood . 1998
  • 9Gambotto A,Tuting T,McVey D L,et al.Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12. Cancer Gene Therapy . 1999
  • 10Armitage J O.Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor. Blood . 1998

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部